HRT Financial’s ENDRA Life Sciences NDRA Stock Holding History

HRT Financial’s Portfolio NDRA Stock Details NDRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-396	Closed	-$2K	–	2961
2024 Q3	$2K	Buy	396 +208	+111%	+$16.1K	﹤0.01%	2299
2024 Q2	$32K	Buy	+188	New	+$80.9K	﹤0.01%	1886
2023 Q3	–	Sell	-6	Closed	-$14K	–	2853
2023 Q2	$14K	Buy	+6	New	+$16.9K	﹤0.01%	2136

Other funds holding NDRA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

HRT Financial's NDRA Position: Q4 2024 in Review

HRT Financial sold out of ENDRA Life Sciences (NDRA) in Q4 2024, closing a stake of 396 shares — an estimated $2K sold.

HRT Financial first reported a position in NDRA in Q2 2023 and held it in 3 quarters. The position peaked at $32K in Q2 2024. 4 funds tracked by Wall St. Rank hold NDRA as of Q4 2024.

HRT Financial reported no remaining ENDRA Life Sciences position as of Q4 2024 after selling out during the quarter.
HRT Financial sold 396 ENDRA Life Sciences shares in Q4 2024, an estimated $2K.
HRT Financial first reported a position in ENDRA Life Sciences in Q2 2023 and held it in 3 quarters.
HRT Financial's ENDRA Life Sciences position peaked at $32K in Q2 2024.
4 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.